The new version of Ashtons Pharmacy News is now available
Our feature article is on our updated Live View system and the launch of the Ashtons Formulary. The Formulary will evolve over time to become a valuable prescribing resource for clinicians.
Trevicta® is a new drug formulation of paliperidone and is a licensed three-month long-term injection, which could revolutionise the treatment of schizophrenia for some patients. This treatment would mean patients only having four injections per year instead of monthly or more frequent injections.
Laurence Sprey, Ashtons’ Managing Director, has written an article about patient safety and medicine management which is a subject that he has been passionate about throughout his professional career. The pharmacy services that Ashtons provide have continuously evolved to improve quality and safety, and we work closely with clinical colleagues to maintain regulatory compliance and best practice.
Ashtons has produced a professional services brochure that provides an overview of the comprehensive range of pharmacy services, supplies, support, and training, which we provide for you. In particular, this will inform you about innovations we have made, such as the additional Live View features, as well as future developments such as electronic prescribing.
Finally, if you or any of your colleagues would like to subscribe free of charge to the Ashtons Pharmacy News so that you don’t miss out, please provide us with your email address and we will ensure you receive your own electronic copy every quarter. Back issues can now be accessed from the Live View system. You can view the new version of the newsletter by clicking here.